Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-κB-dependent process (original) (raw)

References

Achenbach TV, Muller R and Slater EP . (2000). J. Biol. Chem., 275, 32089–32097.
Adams J . (2002a). Trends Mol. Med., 8, S49–S54.
Adams J . (2002b). Curr. Opin. Chem. Biol., 6, 493–500.
Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A and Ben-Neriah Y . (1995). Proc. Natl. Acad. Sci. USA, 92, 10599–10603.
An B, Goldfarb RH, Siman R and Dou QP . (1998). Cell Death Differ., 5, 1062–1075.
Ao Y, Rohde LH and Naumovski L . (2001). Oncogene, 20, 2720–2725.
Arlt A, Vorndamm J, Breitenbroich M, Folsch UR, Kalthoff H, Schmidt WE and Schafer H . (2001). Oncogene, 20, 859–868.
Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, Oliver AA, Factor V, Heuchel R, Mercurio F, Thorgeirsson SS and Sonenshein GE . (2003). Oncogene, 22, 412–425.
Bonny C, Oberson A, Negri S, Sauser C and Schorderet DF . (2001). Diabetes, 50, 77–82.
Carlson BA, Dubay MM, Sausville EA, Brizuela L and Worland PJ . (1996). Cancer Res., 56, 2973–2978.
Carlson B, Lahusen T, Singh S, Loaiza-Perez A, Worland PJ, Pestell R, Albanese C, Sausville EA and Senderowicz AM . (1999). Cancer Res., 59, 4634–4641.
Cartee L, Smith R, Dai Y, Rahmani M, Rosato R, Almenara J, Dent P and Grant S . (2002). Mol. Pharmacol., 61, 1313–1321.
Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P and Grant S . (2001). Cancer Res., 61, 2583–2591.
Chao SH and Price DH . (2001). J. Biol. Chem., 276, 31793–31799.
Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T and Korsmeyer SJ . (2001). Mol. Cell, 8, 705–711.
Chou TC and Talalay P . (1984). Adv. Enzyme Regul., 22, 27–55.
Dai Y, Landowski TH, Rosen ST, Dent P and Grant S . (2002). Blood, 100, 3333–3343.
Dai Y, Yu C, Singh V, Tang L, Wang Z, McInistry R, Dent P and Grant S . (2001). Cancer Res., 61, 5106–5115.
De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R and Franzoso G . (2001). Nature, 414, 308–313.
Decker RH, Dai Y and Grant S . (2001). Cell Death Differ., 8, 715–724.
Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ and Chiao PJ . (2002). Oncogene, 21, 6510–6519.
Glickman MH and Ciechanover A . (2002). Physiol. Rev., 82, 373–428.
Gojo I, Zhang B and Fenton RG . (2002). Clin. Cancer Res., 8, 3527–3538.
Goldberg AL and Rock K . (2002). Nat. Med., 8, 338–340.
Guzman ML, Swiderski CF, Howard DS, Grimes BA, Rossi RM, Szilvassy SJ and Jordan CT . (2002). Proc. Natl. Acad. Sci. USA, 99, 16220–16225.
Hideshima T, Chauhan D, Richardson P, Mitsiades C, Mitsiades N, Hayashi T, Munshi N, Dang L, Castro A, Palombella V, Adams J and Anderson KC . (2002). J. Biol. Chem., 277, 16639–16647.
Hideshima T, Mitsiades C, Akiyama M, Hayashi T, Chauhan D, Richardson P, Schlossman R, Podar K, Munshi NC, Mitsiades N and Anderson KC . (2003). Blood, 101, 1530–1534.
Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, Adams J and Anderson KC . (2001). Cancer Res., 61, 3071–3076.
Hipp MS, Urbich C, Mayer P, Wischhusen J, Weller M, Kracht M and Spyridopoulos I . (2002). Eur. J. Immunol., 32, 2208–2217.
Jesenberger V and Jentsch S . (2002). Nat. Rev. Mol. Cell. Biol., 3, 112–121.
Karp JE, Ross DD, Yang W, Tidwell ML, Wei Y, Greer J, Mann DL, Nakanishi T, Wright JJ and Colevas AD . (2003). Clin. Cancer Res., 9, 307–315.
Kim DM, Koo SY, Jeon K, Kim MH, Lee J, Hong CY and Jeong S . (2003). Cancer Res., 63, 621–626.
Kitada S, Zapata JM, Andreeff M and Reed JC . (2000). Blood, 96, 393–397.
Li B and Dou QP . (2000). Proc. Natl. Acad. Sci. USA, 97, 3850–3855.
Meriin AB, Gabai VL, Yaglom J, Shifrin VI and Sherman MY . (1998). J. Biol. Chem., 273, 6373–6379.
Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T, Munshi N, Treon SP and Anderson KC . (2002). Blood, 99, 4079–4086.
Mitsiades N, Mitsiades CS, Richardson PG, Poulaki V, Tai YT, Chauhan D, Fanourakis G, Gu X, Bailey C, Joseph M, Libermann TA, Schlossman R, Munshi NC, Hideshima T and Anderson KC . (2003). Blood, 101, 2377–2380.
Mori N, Yamada Y, Ikeda S, Yamasaki Y, Tsukasaki K, Tanaka Y, Tomonaga M, Yamamoto N and Fujii M . (2002). Blood, 100, 1828–1834.
Motwani M, Delohery TM and Schwartz GK . (1999). Clin. Cancer Res., 5, 1876–1883.
Ogiso Y, Tomida A, Lei S, Omura S and Tsuruo T . (2000). Cancer Res., 60, 2429–2434.
Orlowski RZ, Stinchcombe TE, Mitchell BS, Shea TC, Baldwin AS, Stahl S, Adams J, Esseltine DL, Elliott PJ, Pien CS, Guerciolini R, Anderson JK, Depcik-Smith ND, Bhagat R, Lehman MJ, Novick SC, O'Connor OA and Soignet SL . (2002). J. Clin. Oncol., 20, 4420–4427.
Parker BW, Kaur G, Nieves-Neira W, Taimi M, Kolhagen G, Shimizu T, Losiewicz MD, Pommier Y, Sausville EA and Senderowicz AM . (1998). Blood, 91, 458–465.
Porcile C, Piccioli P, Stanzione S, Bajetto A, Bonavia R, Barbero S, Florio T and Schettinia G . (2002). Ann. N.Y. Acad. Sci., 973, 402–413.
Rahmani M, Peron P, Weitzman J, Bakiri L, Lardeux B and Bernuau D . (2001). Oncogene, 20, 5132–5142.
Rosato RR, Almenara JA, Cartee L, Betts V, Chellappan SP and Grant S . (2002). Mol. Cancer Ther., 1, 253–266.
Ryan KM, Ernst MK, Rice NR and Vousden KH . (2000). Nature, 404, 892–897.
Sandal T . (2002). Oncologist, 7, 73–81.
Sedlacek HH . (2001). Crit. Rev. Oncol. Hematol., 38, 139–170.
Senderowicz AM . (1999). Invest. New Drugs, 17, 313–320.
Senderowicz AM . (2000). Oncogene, 19, 6600–6606.
Soligo D, Servida F, Delia D, Fontanella E, Lamorte G, Caneva L, Fumiatti R and Lambertenghi Deliliers G . (2001). Br. J. Haematol., 113, 126–135.
Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR and Lipp J . (1998). J. Exp. Med., 188, 211–216.
Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR and Cohen GM . (1999). J. Biol. Chem., 274, 5053–5060.
Suzuki Y, Nakabayashi Y, Nakata K, Reed JC and Takahashi R . (2001). J. Biol. Chem., 276, 27058–27063.
Tan C and Waldmann TA . (2002). Cancer Res., 62, 1083–1086.
Tang L, Boise LH, Dent P and Grant S . (2000). Biochem. Pharmacol., 60, 1445–1456.
Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M and Lin A . (2001). Nature, 414, 313–317.
Teicher BA, Ara G, Herbst R, Palombella VJ and Adams J . (1999). Clin. Cancer Res., 5, 2638–2645.
Thomas JP, Tutsch KD, Cleary JF, Bailey HH, Arzoomanian R, Alberti D, Simon K, Feierabend C, Binger K, Marnocha R, Dresen A and Wilding G . (2002). Cancer Chemother. Pharmacol., 50, 465–472.
Voges D, Zwickl P and Baumeister W . (1999). Annu. Rev. Biochem., 68, 1015–1068.
Vrana JA and Grant S . (2001). Blood, 97, 2105–2114.
Wittmann S, Bali P, Donapaty S, Nimmanapalli R, Guo F, Yamaguchi H, Huang M, Jove R, Wang HG and Bhalla K . (2003). Cancer Res., 63, 93–99.
Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME . (1995). Science, 270, 1326–1331.
Yamaguchi H and Wang HG . (2002). J. Biol. Chem., 277, 41604–41612.
Zhou P, Qian L, Bieszczad CK, Noelle R, Binder M, Levy NB and Craig RW . (1998). Blood, 92, 3226–3239.

Download references